During the past decade, Zala Megyei Szent Rafael Korhaz conducted 38 clinical trials. In the 10-year time frame, 38 clinical trials started and 29 clinical trials were completed, i.e. on average, 76.3% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 20 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Zala Megyei Szent Rafael Korhaz" #1 sponsor was "Eli Lilly and Company" with 6 trials, followed by "Allergan" with 5 trials sponsored, "Pfizer" with 5 trials sponsored, "Bayer" with 4 trials sponsored and "Boehringer Ingelheim" with 4 trials sponsored. Other sponsors include 34 different institutions and companies that sponsored additional 37 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Zala Megyei Szent Rafael Korhaz" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Medtronic" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Quintiles, Inc." with 2 trials as a collaborator and "Abbott" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Zala Megyei Szent Rafael Korhaz" are "Diabetes Mellitus, Type 2" (5 trials), "Gastroparesis" (4 trials), "Myocardial Infarction" (4 trials), "Type 2 Diabetes Mellitus" (4 trials) and "Acute Myocardial Infarction" (3 trials). Many other conditions were trialed in "Zala Megyei Szent Rafael Korhaz" in a lesser frequency.

Most popular intervention types in "Zala Megyei Szent Rafael Korhaz" are "Drug" (55 trials), "Other" (10 trials), "Biological" (6 trials), "Device" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "Carboplatin" (4 trials), "Avelumab" (3 trials), "Cisplatin" (3 trials) and "Dulaglutide" (3 trials). Other intervention names were less common.

The vast majority of trials in "Zala Megyei Szent Rafael Korhaz" are 57 trials for "All" genders, 3 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Zala Megyei Szent Rafael Korhaz". undefined are not yet recruiting, 7 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 35 completed trials in Zala Megyei Szent Rafael Korhaz, 1 suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Zala Megyei Szent Rafael Korhaz, 1 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 41 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".

Zala Megyei Szent Rafael Korhaz has several departments that took part in Clinical trials: "Zala Megyei Kórház,Kardiológia" - 2 trials